Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
MultimericLigands™ - Higher Activity - Lower Endotoxin
AdipoGen Life Sciences' Multimeric Proteins are high-activity constructs in which two trimeric TNFSF ligands are linked via the oligomeric collagen domain of ACRP30 [ACRP30headless] and therefore mimic the membrane-bound forms of the proteins. The Largest Panel of Ultrapotent Multimeric Ligands™ Endogenous TNF superfamily ligands are either active as membrane-form (e.g. FasL, TRAIL, CD40L, OX40L) or are secreted and activated through oligomerization by the binding of proteoglycans at the surface of cells (e.g. APRIL). The oligomerization is triggered |
|
Multimeric FasL™ [MegaFasL™]
FasL (human) (multimeric) (rec.) AG-40B-0130-C010 - 10 μg AG-40B-0130-3010 - 3 x 10 μg (MultiPack) • Multimeric FasL™ very effectively simulates the natural membrane-assisted aggregation of FasL in vivo. Source: HEK 293 cells. Sequence: Human FasL (aa 139-281) is fused at the N-terminus to mouse ACRP30headless (aa 18-111) and a FLAG®-tag. Specificity: Binds to human and mouse Fas. Biological Activity: Induces apoptosis of human JurkatT cells at a concentration of <1ng/ml. Endotoxin Content: <0.02EU/μg purified protein (LAL test; Lonza). Literature References: • Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex: N. Holler, et al.; Mol. Cell. Biol. 23, 1428 (2003) • A Fas agonist induces high levels of apoptosis in hematological malignancies: P. Greaney, et al.; Leuk. Res. 30, 415 (2006) |
Figure: Oligomerisation of FasL (human) efficiently triggers Jurkat cell death. Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (AG-40B-0130), Fc (human):FasL (human) (rec.) (AG-40B-0132), FasL (human) (rec.) (AG-40B-0001) or FasL (human) (rec.) + Enhancer (AG-44B-0001) (2 fold-dilutions, first concentration of 1000ng/ml). Cell death was quantified using PMS/MTS. The oligomeric FasL recombinant proteins (FasL (human) (multimeric), Fc (human):FasL (human) and FasL (human) + Enhancer) kill Jurkat cells at IC50 <0.2ng/ml. |
Multimeric CD40L™
CD40L (human) (multimeric) (rec.) CD40L (human) (multimeric) (rec.) (Certified Serum Grade)
|
Figure: CD40L (human) (multimeric) (rec.) (Prod. No. AG-40B-0010) does not need an enhancer to induce B cell activation. |
CD40L (human) (multimeric) (rec.) (Biotin) |
AG-40B-0010B-C010 AG-40B-0010B-3010 |
10 μg MultiPack 3 x 10 μg |
CD40L (mouse) (multimeric) (rec.) |
AG-40B-0020-C010 AG-40B-0020-3010 |
10 μg MultiPack 3 x 10 μg |
CD40L (mouse) (multimeric) (rec.) (Biotin) |
AG-40B-0020B-C010 AG-40B-0020B-3010 |
10 μg MultiPack 3 x 10 μg |
CD40L (rat) (multimeric) (rec.) >> BULK available for in vivo studies! |
AG-40B-0088-C010 AG-40B-0088-3010 |
10 μg MultiPack 3 x 10 μg |
Full Panel of Multimeric Ligands™
APRIL (human) (multimeric) (rec.) | AG-40B-0017-C010 AG-40B-0017-3010 |
10 μg MultiPack 3 x 10 μg |
APRIL (human) (H98) (multimeric) (rec.) | AG-40B-0088-C010 AG-40B-0088-3010 |
10 μg MultiPack 3 x 10 μg |
APRIL (mouse) (multimeric) (rec.) | AG-40B-0089-C010 AG-40B-0089-3010 |
10 μg MultiPack 3 x 10 μg |
APRIL (mouse) (H98) (multimeric) (rec.) | AG-40B-0035-C010 AG-40B-0035-3010 |
10 μg MultiPack 3 x 10 μg |
OX40L (mouse) (multimeric) (rec.) | AG-40B-0029-C010 | 10 μg |
TNF-α (human) (multimeric) (rec.) >> Activates TNF-R1 and TNF-R2! |
AG-40B-0019-C010 | 10 μg |
For more information on all AdipoGen Multimeric Ligands please search this website.
For Product Inquiries: info@adipogen.com
More Information |
Product Flyer |
|